Login

Fullsix Unveils Diverse Pepper Solutions Across Retail, Banking, Hospitality, and Healthcare | Francesco Meani , CEO at Fullsix Spa 00:10:00

Share On Facebook Share On Twitter

Francesco Meani is the CEO at Fullsix Spa

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Azure Minerals' Andover Lithium Project: A Transformative Year with Major Discoveries and Takeover Offer
00:10:00
Blade CEO Rob Wiesenthal on Mad Money with Jim Cramer | Robert S Wiesenthal - CEO of Blade Air Mobility Inc.
00:10:00
Francisco Partners' DJ Deb on Tech Investment Trends and Market Risks | Dipanjan Deb, CEO, Francisco Partners.
00:10:00
Delivering Excellence in Aerospace & Defense Investment Banking
00:10:00
M&A Outlook and the Importance of Timing in Deals
00:10:00
Interview with Jonathan Sands: Director of Sands Wealth Management on Sponsoring Project Yorkshire
00:10:00
VTEX's latest fundraising propelled it to unicorn status; Co-Founder and Co-CEO Mariano Gomide de Faria discusses the company's ongoing growth.|Gomide de Faria is our Founder and Co-Chief Executive Officer,
00:10:00
The Square and the Tower: Neil Ferguson's Perspective on Networks and Hierarchies in History|Niall Ferguson
00:10:00
Interview with Dan Dolghin | NICHOLAS PANTAZELOS, CEO, Comvex SACMVX:BUH
00:10:00
Abbott Capital Boosts Recruitment Efficiency with OneWire
00:10:00
Strategic Adaptation and Value Creation in 2024 | David Mussafer, Chairman ,  Advent International.
00:10:00
Navigating Market Opportunities: Insights from a Diverse Range of Companies

© 2017 - Neuhu+